BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miyazaki T, Shirakami Y, Mizutani T, Maruta A, Ideta T, Kubota M, Sakai H, Ibuka T, Genovese S, Fiorito S, Taddeo VA, Epifano F, Tanaka T, Shimizu M. Novel FXR agonist nelumal A suppresses colitis and inflammation-related colorectal carcinogenesis. Sci Rep 2021;11:492. [PMID: 33436792 DOI: 10.1038/s41598-020-79916-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Cariello M, Zerlotin R, Pasculli E, Piccinin E, Peres C, Porru E, Roda A, Gadaleta RM, Moschetta A. Intestinal FXR Activation via Transgenic Chimera or Chemical Agonism Prevents Colitis-Associated and Genetically-Induced Colon Cancer. Cancers 2022;14:3081. [DOI: 10.3390/cancers14133081] [Reference Citation Analysis]
2 Huang X, Fan M, Huang W. Pleiotropic roles of FXR in liver and colorectal cancers. Mol Cell Endocrinol 2022;543:111543. [PMID: 34995680 DOI: 10.1016/j.mce.2021.111543] [Reference Citation Analysis]
3 Liu D, Zhao R, Wu Y, Wang Y, Yang R, Ke X. Variation in the Efficacy of Anti-Ulcerative Colitis Treatments Reveals the Conflict Between Precipitating Compatibility of Traditional Chinese Medicine and Modern Technology: A Case of Scutellaria-Coptis. Front Pharmacol 2022;13:819851. [PMID: 35517805 DOI: 10.3389/fphar.2022.819851] [Reference Citation Analysis]
4 Biagioli M, Marchianò S, Carino A, Di Giorgio C, Santucci L, Distrutti E, Fiorucci S. Bile Acids Activated Receptors in Inflammatory Bowel Disease. Cells 2021;10:1281. [PMID: 34064187 DOI: 10.3390/cells10061281] [Reference Citation Analysis]
5 Fiorito S, Epifano F, Marchetti L, Genovese S. Semisynthesis of Selenoauraptene. Molecules 2021;26:2798. [PMID: 34068532 DOI: 10.3390/molecules26092798] [Reference Citation Analysis]